T cell mediated immunity to influenza: Mechanisms of viral control

Trends in Immunology

Volumn 35, Issue 8, 2014, Pages 396-402

  La Gruta, Nicole L ^a   Turner, Stephen J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Immunological memory MHC class I MHC class II vaccination; Influenza A virus

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIGEN;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; HUMAN; IMMUNE EVASION; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A; PATHOGENICITY; TRANSMISSION; VIROLOGY;

ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNE EVASION; IMMUNITY, CELLULAR; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 84905095220     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.06.004     Document Type: Review

References (70)

1. Doherty P.C., Christensen J.P. Accessing complexity: the dynamics of virus-specific T cell responses. Annu. Rev. Immunol. 2000, 18:561-592.
2. + T-cell effector and memory responses cooperate to provide potent immunity against respiratory virus. Immunol. Rev. 2013, 255:149-164.
3. Thomas P.G., et al. Cell-mediated protection in influenza infection. Emerg. Infect. Dis. 2006, 12:48-54.
4. Doherty P.C., et al. Influenza and the challenge for immunology. Nat. Immunol. 2006, 7:449-455.
5. Lee L.Y., et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J. Clin. Invest. 2008, 118:3478-3490.
6. + T-cell responses. Immunol. Cell Biol. 2013, 91:184-194.
7. Sridhar S., et al. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat. Med. 2013, 19:1305-1312.
8. + T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 2012, 18:274-280.
9. Gotch F., et al. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 1987, 326:881-882.
10. + T-cell responses to influenza A virus in HLA-A2 individuals. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9178-9183.
11. Nayak J.L., et al. Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins. Viral Immunol. 2010, 23:169-180.
12. Alam S., et al. CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection. J. Virol. 2014, 88:314-324.
13. Corti D., et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J. Clin. Invest. 2010, 120:1663-1673.
14. Guillaume P., et al. Soluble MHC-peptide complexes: tools for the monitoring of T cell responses in clinical trials and basic research. Cancer Immun. 2009, 9:7.
15. Hadrup S.R., et al. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat. Methods 2009, 6:520-526.
16. + T cell phenotypes. Immunity 2012, 36:142-152.
17. Forrest B.D., et al. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children. Clin. Vaccine Immunol. 2008, 15:1042-1053.
18. Kreijtz J.H., et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007, 25:612-620.
19. Kreijtz J.H., et al. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J. Virol. 2008, 82:5161-5166.
20. McMichael A.J., et al. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 1983, 309:13-17.
21. Epstein S.L. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J. Infect. Dis. 2006, 193:49-53.
22. + T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 1997, 159:5197-5200.
23. -/- mice. Viral Immunol. 2008, 21:341-346.
24. Brincks E.L., et al. CD8 T cells utilize TRAIL to control influenza virus infection. J. Immunol. 2008, 181:4918-4925.
25. Jenkins M.R., et al. Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL. J. Immunol. 2007, 179:64-70.
26. + T cells. J. Immunol. 2008, 181:3818-3822.
27. Mintern J.D., et al. Cutting edge: tissue-resident memory CTL down-regulate cytolytic molecule expression following virus clearance. J. Immunol. 2007, 179:7220-7224.
28. + T cells. Blood 2012, 120:3237-3245.
29. + T cell responses: correlation of cytokine profile and TCR avidity. J. Immunol. 2004, 172:5553-5560.
30. Stinchcombe J.C., Griffiths G.M. Secretory mechanisms in cell-mediated cytotoxicity. Annu. Rev. Cell Dev. Biol. 2007, 23:495-517.
31. Kohlmeier J.E., Woodland D.L. Immunity to respiratory viruses. Annu. Rev. Immunol. 2008, 27:61-82.
32. + T cell response to respiratory virus infections. Immunity 2008, 29:101-113.
33. + T cells in the lung airways during respiratory virus challenge. Immunity 2010, 33:96-105.
34. Cerwenka A., et al. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J. Immunol. 1999, 163:5535-5543.
35. La Gruta N.L., et al. A question of self-preservation: immunopathology in influenza virus infection. Immunol. Cell Biol. 2007, 85:85-92.
36. Sun J., et al. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 2009, 15:277-284.
37. + effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment. Virology 2010, 404:225-230.
38. Breitfeld D., et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J. Exp. Med. 2000, 192:1545-1552.
39. Lee S.K., et al. B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J. Exp. Med. 2011, 208:1377-1388.
40. Linterman M.A., et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 2010, 207:353-363.
41. Zotos D., et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 2010, 207:365-378.
42. Gerhard W., et al. Role of the B-cell response in recovery of mice from primary influenza virus infection. Immunol. Rev. 1997, 159:95-103.
43. Wrammert J., et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 2011, 208:181-193.
44. + T cells protect against influenza through multiple synergizing mechanisms. J. Clin. Invest. 2012, 122:2847-2856.
45. Alam S., Sant A.J. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus. J. Virol. 2011, 85:13310-13321.
46. + T cells in immunity to viruses. Nat. Rev. Immunol. 2012, 12:136-148.
47. + T cells induce innate responses independently of pathogen. Nat. Med. 2010, 16:558-564.
48. Brown D.M., et al. Multifunctional CD4 cells expressing gamma interferon and perforin mediate protection against lethal influenza virus infection. J. Virol. 2012, 86:6792-6803.
49. +-T-cell-deficient mice. J. Virol. 2002, 76:12388-12393.
50. Johnson S., et al. Selected Toll-like receptor ligands and viruses promote helper-independent cytotoxic T cell priming by upregulating CD40L on dendritic cells. Immunity 2009, 30:218-227.
51. + memory T cells. Nat. immunol. 2011, 12:908-913.
52. + CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J. Immunol. 2010, 185:2382-2392.
53. + T-cell effector differentiation by modulating IL-2 homeostasis. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:7529-7534.
54. + T cell responses. J. Exp. Med. 2003, 198:889-901.
55. + T cell responses to influenza. J. Exp. Med. 2013, 210:1591-1601.
56. + T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J. Immunol. 2005, 174:3344-3351.
57. Pulendran B., et al. Systems vaccinology. Immunity 2010, 33:516-529.
58. Heath W.R., Carbone F.R. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 2009, 10:1237-1244.
59. + dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 2004, 172:1996-2000.
60. + dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells. J. Immunol. 2011, 187:6011-6021.
61. + dendritic cells control CD8 T cell immunity during acute influenza infection. PLoS ONE 2013, 8:e66136.
62. Belz G.T., et al. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8670-8675.
63. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
64. - but not plasmacytoid dendritic cells. J. Exp. Med. 2008, 205:1621-1634.
65. + dendritic cells. J. Exp. Med. 2010, 207:1261-1271.
66. + dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 2010, 207:189-206.
67. Berkhoff E.G., et al. The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro. Clin. Exp. Immunol. 2007, 148:296-306.
68. Berkhoff E.G., et al. A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J. Virol. 2004, 78:5216-5222.
69. + T-cell clones. J. Gen. Virol. 2007, 88:530-535.
70. Boon A.C., et al. Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes. J. Virol. 2002, 76:2567-2572.